Pamela Woodard, MD, of the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, discusses the challenges and benefits of being an early adopter of this technology.
[[{"type":"media","view_mode":"media_crop","fid":"8216","attributes":{"alt":"Siemens Biograph mMR PET/MR","class":"media-image media-image-left","id":"media_crop_4872934844629","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"217","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]Pioneering a new imaging technology is far more complicated than plugging it in and scanning patients. At the Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, implementing the Siemens Biograph mMR hybrid PET/MR system requires the radiologists to develop the protocols.
"It's a very new piece of equipment," said Pamela Woodard, MD, of the Center for Clinical Imaging Research (CCIR), Mallinckrodt Institute of Radiology, Washington University School of Medicine. "It's not like a CT scanner that everyone has been using for 35 years and you just start scanning."
Washington University School of Medicine is only the third site in the U.S. to have this equipment, with two other sites set to come online soon. Siemens received FDA 510(k) clearance in June 2011 for the Biograph mMR, the first system to allow for simultaneous whole-body scanning by MR and PET.
[[{"type":"media","view_mode":"media_crop","fid":"11970","attributes":{"alt":"Pamela Woodward","class":"media-image","id":"media_crop_590670178982","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"216","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]And despite the start-up challenges, the lower dose and the simultaneous scans provide some major benefits for patients, according to Woodard. In this podcast, Woodard explains how this technology is being used, why her institution became an early adopter, and what they've learned so far.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.